"From lobby firms to top officials, a look at how Bayer built access and secured favors"
"The White House invokes the Defense Production Act to guarantee supplies of elemental phosphorus and glyphosate-based herbicides. Regulators reapprove dicamba, a Bayer herbicide twice blocked by federal courts, and clear the way for new pesticides containing toxic, persistent PFAS “forever” chemicals.
And the U.S. Justice Department urges the U.S. Supreme Court to erase billions of dollars of Bayer’s liability for its glyphosate-based Roundup weed killer – placing the weight of the executive branch on the side of a foreign company against thousands of Americans who say Bayer’s products caused their cancers.
Over the past year, the administration under President Donald J. Trump has delivered a string of victories to Bayer, the German agrichemical and pharmaceutical giant that merged with Monsanto in 2018 to become the world’s leading manufacturer of genetically modified seeds and pesticides.
Pesticide industry influence in Washington is not new. The Biden administration also delivered wins to Bayer, including defending pesticide deregulatory measures. But Bayer’s big wins with the Trump administration come as the company seeks sweeping legal protections from cancer lawsuits – at a time when a growing body of scientific research links glyphosate to cancer and other chronic diseases, and cancer rates are rising among young people across the U.S. Corn Belt."
Stacy Malkan reports for U.S. Right To Know February 24, 2026.
